Matrix Gla Protein (MGP) (Middle Region) Peptide
MGP
Reactivity: Human
Host: Synthetic
BP, IHC, WB
Catalog No. ABIN980069
Quick Overview for Matrix Gla Protein (MGP) (Middle Region) Peptide (ABIN980069)
Target
MGP
(Matrix Gla Protein (MGP))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MGP antibody (Catalog #: ARP51308_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
Matrix Gla Protein (MGP) (AA 20-96) peptide (His tag)
MGP Reactivity: Human Host: Escherichia coli (E. coli) SDS
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MGP (Matrix Gla Protein (MGP))
-
Background
-
MGP is associates with the organic matrix of bone and cartilage. MGP is thought to act as an inhibitor of bone formation.
Alias Symbols: GIG36, MGLAP, NTI
Protein Interaction Partner: BMP2,BMP2
Protein Size: 103 -
Molecular Weight
- 12 kDa
-
Gene ID
- 4256
-
NCBI Accession
- NM_000900, NP_000891
-
UniProt
- P08493
Target
-
You are here:
